Drug discovery

Results: 2977



#Item
11Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

Application of Natural Resources to Drug Discovery in Eisai Research and Development of Eribulin mesylate Katsuya Tagami, Eisai Co., Ltd. Eribuin mesylate is a first-in class, non-taxane microtubule dynamics inhibitor th

Add to Reading List

Source URL: apac-asia.com

Language: English - Date: 2017-05-01 03:53:28
    12FACULTY OF SCIENCE, ENVIRONMENT AND TECHNOLOGY Institute of Applied Sciences Centre of Drug Discovery and Conservation WDCM WORKSHOP REPORT (9th – 23rd of September, 2016)

    FACULTY OF SCIENCE, ENVIRONMENT AND TECHNOLOGY Institute of Applied Sciences Centre of Drug Discovery and Conservation WDCM WORKSHOP REPORT (9th – 23rd of September, 2016)

    Add to Reading List

    Source URL: www.wdcm.org

    Language: English - Date: 2016-12-22 02:01:48
      13XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy , target validation and predictive biomarker discovery studies. Pascal Leuraud, Stefano Cairo, Olivier Déas, Marie-France

      XenTech patient-derived xenograft (PDX) panels: a clinically relevant platform for drug efficacy , target validation and predictive biomarker discovery studies. Pascal Leuraud, Stefano Cairo, Olivier Déas, Marie-France

      Add to Reading List

      Source URL: www.xentech.eu

      Language: English - Date: 2015-12-22 11:05:04
        14REPORT ON DDTWC & GBC 2015 INTRODUCTION The third conferences of the series Drug Discovery & Therapy World CongressDDTWCand the Global Biotechnology CongressGBC 2015), were organized by Eureka Confer

        REPORT ON DDTWC & GBC 2015 INTRODUCTION The third conferences of the series Drug Discovery & Therapy World CongressDDTWCand the Global Biotechnology CongressGBC 2015), were organized by Eureka Confer

        Add to Reading List

        Source URL: eureka-science.com

        Language: English - Date: 2016-12-08 04:28:27
          15Plasma Protein Binding: Friend or Foe in Drug Discovery? Kevin Beaumont and Tristan Maurer Pharmacokinetics, Dynamics and Metabolism Pfizer Worldwide Research and Development Memorial Drive, Cambridge

          Plasma Protein Binding: Friend or Foe in Drug Discovery? Kevin Beaumont and Tristan Maurer Pharmacokinetics, Dynamics and Metabolism Pfizer Worldwide Research and Development Memorial Drive, Cambridge

          Add to Reading List

          Source URL: www.nedmdg.org

          Language: English - Date: 2015-06-25 17:16:29
            16Strengthening Academic Researchers’ Drug Discovery Capabilities through DSANJ Business Meeting 5th APAC April 8, 2016 Imperial Hotel, Tokyo

            Strengthening Academic Researchers’ Drug Discovery Capabilities through DSANJ Business Meeting 5th APAC April 8, 2016 Imperial Hotel, Tokyo

            Add to Reading List

            Source URL: apac-asia.com

            Language: English - Date: 2016-05-24 02:04:58
              17Systems Biology Seminar Talk Pathway analysis tools for drug discovery: applications in liver cancer, cartilage degeneration and melanoma Prof. Leonidas Alexopoulos National Technical University of Athen

              Systems Biology Seminar Talk Pathway analysis tools for drug discovery: applications in liver cancer, cartilage degeneration and melanoma Prof. Leonidas Alexopoulos National Technical University of Athen

              Add to Reading List

              Source URL: www.centersysbio.uni-stuttgart.de

              Language: English - Date: 2016-06-14 05:43:03
                18Page 1 of 12 Isaac Madan March 14, 2014 BMI 258, Final project The potential of genome-based computational methods for drug repositioning Drug discovery and development are critical components in today’s healthcare

                Page 1 of 12 Isaac Madan March 14, 2014 BMI 258, Final project The potential of genome-based computational methods for drug repositioning Drug discovery and development are critical components in today’s healthcare

                Add to Reading List

                Source URL: biochem158.stanford.edu

                Language: English - Date: 2014-03-19 06:28:35
                  19National call for the generation of human recombinant antibodies The Human Antibody Therapeutics (HAT) facility is part of the Drug Discovery and Development (DDD) Platform at SciLifeLab. In short, we help

                  National call for the generation of human recombinant antibodies The Human Antibody Therapeutics (HAT) facility is part of the Drug Discovery and Development (DDD) Platform at SciLifeLab. In short, we help

                  Add to Reading List

                  Source URL: www.scilifelab.se

                  Language: English - Date: 2017-10-05 08:25:25
                    20This conference aims at discussing the state of the art of computational methods as effective tools for drug discovery. Toward this end, we have integrated topics that are, and will remain, central to the field, such as

                    This conference aims at discussing the state of the art of computational methods as effective tools for drug discovery. Toward this end, we have integrated topics that are, and will remain, central to the field, such as

                    Add to Reading List

                    Source URL: sbdd2017.epfl.ch

                    Language: English - Date: 2017-09-05 08:48:48